Blumhouse Reassesses Strategy After 'M3GAN 2.0' Underperformance
Blumhouse, once dominant in horror, is reevaluating its strategy after four consecutive box office misses in 2024, including the underperforming sequel M3GAN 2.0, which failed to meet expectations despite the original's success. The company is focusing on more traditional horror releases and learning from this year's setbacks to adapt to a saturated market and changing audience preferences.







